Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

16.7%

2 terminated/withdrawn out of 12 trials

Success Rate

71.4%

-15.1% vs industry average

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

N/A

6(60.0%)

Phase 3

3(30.0%)

Phase 2

1(10.0%)

10Total

N/A(6)

Phase 3(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials

NCT05780918Not ApplicableActive Not Recruiting

A Communication Tool to Improve Communication in the ICU

Role: collaborator

NCT03936361Phase 3Recruiting

Statins In Intracerbral Hemorrhage

Role: collaborator

NCT03818854Phase 2Completed

Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome

Role: collaborator

NCT03111043Completed

Head-to-pelvis Computed Tomography Evaluation of Sudden Death Survivors

Role: collaborator

NCT04275258Not ApplicableUnknown

Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder

Role: collaborator

NCT03584386Not ApplicableCompleted

CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention

Role: collaborator

NCT03913403Unknown

Study of Treatment's Echocardiographic Mechanisms

Role: collaborator

NCT02516228Not ApplicableTerminated

Transcranial Electrical Neuromodulation for Suppressing Epileptiform Discharges

Role: collaborator

NCT00607620Not ApplicableCompleted

Disseminating Organizational SBI Services at Trauma Centers

Role: collaborator

NCT00395161Phase 3Terminated

The CRISIS Prevention Study

Role: collaborator

NCT00105963Not ApplicableUnknown

Prevention of Shaken Baby Syndrome

Role: lead

NCT00004817Phase 3Completed

Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures

Role: collaborator

All 12 trials loaded